跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 566 条关于
“TNFi”
全部
566
临床试验
461
药物
77
机构
1
资讯
27
去年
Ignite Biomedical's AI-Driven TNFi Treatment Response Predictor Achieves Analytical Validation
去年
FDA Approves Bimekizumab (Bimzelx) for Psoriatic Arthritis and Axial Spondyloarthritis
去年
Bimekizumab Shows Sustained Efficacy in Psoriatic Arthritis at 2 Years
去年
Bimekizumab Demonstrates Sustained Three-Year Efficacy in Psoriatic Arthritis and Axial Spondyloarthritis
2年前
Biomarkers Identified to Predict Treatment Response in Psoriatic Arthritis
去年
Scipher Medicine Expands Precision Medicine Partnerships to Transform Rheumatoid Arthritis Treatment
去年
Bimekizumab Shows Sustained Efficacy in Psoriatic Arthritis and Axial Spondyloarthritis in New Two-Year Data
去年
Rheumatology Update: Bimekizumab Approved for PsA, Digital Therapies Advance, and AI Aids Fibromyalgia Diagnosis
去年
Scipher Medicine and Kythera Labs Form Strategic Partnership to Advance Precision Medicine in Rheumatology
去年
Johnson & Johnson Seeks FDA Approval for Tremfya to Treat Pediatric Psoriasis and Arthritis
第 1 页,共 3 页
上一页
下一页